您所在的位置:
作者:关翘楚
单位:Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

摘要

Introduction / background

To compare the short-term clinical outcomes of erenumab, galcanezumab, and rimegepant in patients with chronic migraine, focusing on headache burden, pain severity, and pericranial tenderness.

Methods

This real-world longitudinal study included 95 patients receiving erenumab (n=40), galcanezumab (n=19), or rimegepant (n=36), with assessments at baseline and months 1–3. Outcomes included monthly headache days (MHD), attack frequency, visual analog scale (VAS) scores, responder rates, and pericranial tenderness. Overlap weighting, longitudinal regression models, and exact tests were used for statistical analyses.

Results

All three treatments were associated with improvements in headache outcomes. Overlap-weighted mean MHD decreased from 25.04 to 11.75, 24.96 to 7.32, and 23.82 to 9.20 days/month, respectively, by month 3, without significant between-group differences (all P>0.05). Month 3 ≥50% MHD responder rates were 72.41%, 73.33%, and 73.53%, respectively. Adjusted VAS scores differed between treatments (P<0.001), with lower scores in the galcanezumab group, although the treatment-by-time interaction was not significant (P=0.306). Pericranial tenderness positivity decreased from 80.00%, 57.89%, and 69.44% at baseline to 44.83%, 20.00%, and 44.12% at month 3, respectively. No significant difference in headache response was observed between pooled CGRP monoclonal antibodies and rimegepant among patients with baseline tenderness.

Conclusions

All three CGRP-targeted therapies were associated with reduced headache burden and pain severity, accompanied by declining pericranial tenderness positivity. Galcanezumab showed lower adjusted VAS scores, but comparative findings require cautious interpretation. Pericranial tenderness warrants further investigation as a complementary clinical outcome.

相关会议

更多
“医”路携手,“药”有作为一基层抗感染系列学术研讨会(3)
2026-11-30
北京
重庆市医师协会器官移植医师分会2026年学术年会
2026-11-30
待定

相关直播

更多
第八届上海国际癌症大会
2026-06-03
上海静安英迪格酒店
观看回放
产前咨询
2026-09-01
产前咨询
观看回放
冠心病及腔内影像生理学规范诊疗系列课程:左心室血栓的诊疗新进展
2026-11-17
阜外医院冠心病一病区
观看回放

最新视频

更多
糖尿病分型诊断中国专家共识解读
徐静
西安交通大学第二附属医院
李宗恩授课
李宗恩
病例分享
王攀霞
喀什市人民医院
高脂血症与急性胰腺炎
高静
新疆医科大学第五附属医院